what are the Recommendations for Choice of SAVR Versus TAVI for Patients for
Whom a Bioprosthetic AVR Is Appropriate
Referenced studies that support the recommendations are
summarized in Online Data Supplement 11 to 13.?
For symptomatic patients with severe AS who are 65 to 80 years of age and have no anatomic contraindication to transfemoral TAVI, either SAVR or transfemoral TAVI is recommended after shared decision-making about the balance between expected patient longevity and valve durability.